Access a wide range of related resources as well as the actual recording of the Bayer-sponsored symposium that took place at EHRA 2022 Congress!
In this session, you will learn about
- the breadth and depth of evidence of rivaroxaban for stroke prevention in atrial fibrillation across patient populations
- the importance of patient identification and screening for AF
- the importance of adherence to NOAC therapy and its impact on both clinical outcomes and costs in AF
Chair: John Camm | Speakers: Keith Fox, Emma Svennberg, Tatjana Potpara
See our chairman outlining the key topics of the session!
Listen to a folow-up podcast with John Camm & Keith Fox
Stay tuned for expert videos with the faculty of the session
Read throught the detailed agenda of the session
Acces the presented slide deck of the symposium
Study a scientific summary of the session
Learn more about Stroke Prevention
Craig Coleman – Protecting the frail patient from AF-related stroke
What should be considered when treating frail patients with AF?
Worsening renal function in a patient with atrial fibrillation and diabetes
Get to know John - a patient with atrial fibrillation and diabetes.
The Kidneys Matter in Patients with Atrial Fibrillation and Diabetes
Why it is important to preserve renal function especally in patients with AF and Diabetes.
Anticoagulation in high risk patients with atrial fibrillation – Episode 1
In this episode, Dr Yassir Javaid gives us his advice on getting to know your patients with atrial fibrillation and diabetes , Professor Craig Coleman explains the results of the CALLIPER study and Dr Manesh Patel and Dr Christian Ruff look at the issues surrounding stroke prevention in an older patient with renal impairment and tell us how COVID-19 is affecting the treatment of patients with cardiovascular disease.
Anticoagulation in high risk patients with atrial fibrillation - Episode 2
In this episode, Professor Peter Rossing talks about the links between atrial fibrillation and diabetes, Professor Craig Coleman takes us through the RIVAL study and Dr Manesh Patel and Dr Christian Ruff discuss the management of an obese patient with atrial fibrillation and diabetes.
Anticoagulation in high risk patients with atrial fibrillation – Episode 3
In this episode, Dr Rónán Collins talks about the links between atrial fibrillation and renal impairment, Dr Hendrik Bonnemeier takes us through the RELOADED study and Dr Manesh Patel and Dr Christian Ruff discuss the management of an patient with atrial fibrillation, diabetes and renal impairment.
Book a 1:1 with a Bayer scientific expert in your local language
Explore Bayer's cardiovascular products and trials
Learn more about Venous and Arterial Thrombosis
Discover ESC-EHRA CME Webinars
How to improve patient compliance necessitating oral anticoagulation due to non-valvular atrial fibrillation?
After watching this webinar, participants will get an overview of the right dosing for different patient groups and bleeding risk management; and familiar with management strategies to improve patient compliance.
Assessing Comorbidities in AF patients as “AF never comes alone”
After watching the webinar, participants will be able to: identify the concepts underlying comorbidity management in the 2020 ESC Clinical Practice Guidelines on Atrial Fibrillation; and understand the relationship between diabetes and AF.
Management of AF patients undergoing PCI: Where are we now
After watching the webinar, participants will know: right dosing for different patients; bleeding risk management; and management at 12 months’ time post PCI
Explore Medscape CME Resources
Stroke Prevention in Atrial Fibrillation: A Virtual Case Simulation
Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation.
Appropriate Treatment of Atrial Fibrillation: Which Dose for Which Patient?
Get an update on the criteria for appropriate dose reduction of non-vitamin K antagonist oral anticoagulants (NOACs) for stroke reduction in patients with atrial fibrillation (AF).
Atrial Fibrillation in Patients With Renal Impairment: How to Manage
Find out more about the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with declining renal function.
